Antenatal HIV testing: evaluation of uptake and women's attitudes in a low risk population. by McCracken, G. et al.
The Ulster Medical Journal, Volume 73, No. 2, pp. 92-95, November 2004.
Antenatal HIV testing:
evaluation ofuptake and women's attitudes in a low risk population
G McCracken, J McGeagh, R Roberts
Accepted 6 October 2004
SUMMARY
The number of HIV-positive heterosexuals in the UK is increasing, with a resultant increase in
thenumberofpregnantwomenwhoareHIV-positive. ThebenefitsofdiagnosinganHIV-positive
woman antenatally are well established. The Department ofHealth ofEngland issued guidelines
recommending named voluntary antenatal testing, with a view to achieving a maternal diagnosis
rate of 90% by December 2002. In Northern Ireland the policy was distributed in 2003. The
screening programme in our hospital had an uptake rate of98.7%. Responses to a questionnaire
toevaluatethe process indicatethatHIVtestingwasassociatedwithlowlevels ofanxietyandthat
patients were well satisfied with the counselling they received.
INTRODUCTION
ThenumberofHIV-positive heterosexuals inthe
UK is increasing, and this has resulted in an
increase in the number of pregnant women who
are HIV-positive. In the year 2000, 46% of the
2,868 newly diagnosed cases of HIV in the UK
werelikelytohavebeenacquiredheterosexually,
the majority originating from high prevalence
areas such as sub-Saharan Africa. Data from
unlinked anonymous screening suggests that450
HIV-positive women gave birth in the UK in
2000, with two-thirds occurring in London.
Throughout the rest ofthe UK, the incidence has
remained at less than 3 per 10,000.
The benefits of diagnosing an HIV-positive
woman before delivery, and preferably in the
firsttrimesterofpregnancy, arewellestablished:
avoidance of breastfeeding 1 and anti-retroviral
therapy 2decreaseverticaltransmissionfrom30%
to 5-8%. The benefit ofother interventions, such
as elective caesarean section is less clear: one
study showed a five-fold reduction in rates of
transmission rateinthe caesarean sectiongroup,3
whereas Beckermann's group have been
advocating normal vaginal delivery in women
receiving anti-retroviral therapy.4
The idea of antenatal screening for HIV is not
new. One ofthe first pilot studies in the UK was
reported in the BJOG in 1996,5 and soon
afterwardstheUKNationalScreeningCommittee
recommendedthatall pregnantwomenintheUK
be offered antenatal screening. It wasn't until
1999 that the Department of Health in England
issuedguidelinesrecommendingnamedvoluntary
antenatal testing, with a view to achieving a
maternal diagnosis rate of 90% by December
2002.6 This was reinforcedby aRoyal College of
Obstetricians andGynaecologists draftGreentop
Guideline published in February 2003.7
Currently, antenatal screeningpolicies vary from
universal testing to selective testing (for those
with recognised risk factors), and even request
only testing. There are also differences in the
amount of information given prior to the HIV
test,rangingfromcomprehensive tominimal. An
important factor to remember is that actually
offering the test to low risk women may in itself
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causeanxietyandalsodisharmonybetweenhealth
provider and patient. A study performed in
Edinburgh showed that neither anxiety nor
satisfaction was affected by the amount of
information given.8
The Ulster Community & Hospitals Trust was
identified as a pilot site for implementation of
universal antenatal HIV screening in Northern
Ireland. Patients were posted a locally produced
information leaflet prior to their first antenatal
clinic. This highlighted the benefits ofscreening
for HIV and other infections. At the booking
clinic, trained midwives initiated a pre-test
discussion and obtained written consent before
performing HIV screening. Part of the pilot
scheme involved evaluation of the process,
including assessment of the women's attitudes
towards it.
METHODS
The evaluation was conducted from 1st May
2003 to 31stJuly 2003. All women attending for
their anomaly scan at 20 weeks gestation were
asked to complete a questionnaire measuring
their knowledge about the HIV test, attitudes to
thetest,concernsoranxietiesaboutit, andreasons
foragreeingtoitordecliningit. Thewomenwere
informed that participation was voluntary and
they wereassuredofanonymity. Writtenconsent
was obtained from each woman.
A literature search was carried out in Medline to
identifypublications onantenatalHIVscreening.
On the basis ofthis, a patient questionnaire was
devised to avoid leading questions and to allow
the patient to record options not encompassed in
the questionnaire. Once completed, the
questionnaires werereturnedtotheclinic andthe
information was collated by the quality and
effectiveness department.
RESULTS
FromMay 2003 toJuly 2003,232 questionnaires
were completed andreturned. Ofthe 232 women
questioned, 229 (98.7%) opted to have the HIV
test. Thereasons foropting inoroutare shownin
Tables Ia and Ib, respectively. The main reason
foroptinginwasthatwomenfeltitwasbeneficial
for themselves, their baby, or both (114/229,
49.8%), whereas the main reason for opting out
was because ofperceived low risk (2/4,50%).
TABLE IB
Reasonsfor opting out ofthe HIV test
Reasonfor opting out Number Percentage
Didn't think she was at risk. 2 50
Didn't know if she was tested. 1 25
Just a routine test. 1 25
Prior to becoming pregnant, 57.4% (132/230) of
women were aware of HIV screening and 86%
(197/229)thoughtallwomenshouldbescreened.
At the first antenatal appointment, 89.7% (201/
224) ofwomenhadtheopportunityto discuss the
bloodtest;97.1% (204/210)statedquestionswere
answered to their satisfaction and 84.7% (189/
223) felttheinformation given aboutthe testwas
just right.
Ofthe232 women, 6.5% (15)hadconcerns about
havingthetest; theconcerns identifiedare shown
inTableII.Ofthe221 responsesregardinganxiety
about having the test, 94.6% (209/221) were
eitherslightlyanxiousornotanxious atall. Atthe
time of testing, 74.3% (162/218) felt there was
enough privacy to discuss testing and voice any
concerns.70.4% (157/223)statedthattheysigned
TABLE I
Reasonsfor opting to have the HIV test
Reasonsfor opting in Number Percentage
Beneficial to respondent or baby to know. 114 49.8
Respondent felt the test would be negative. 75 32.7
It was offered and therefore respondent felt she should accept. 41 17.9
Midwife advised respondent to have the test. 17 7.4
Respondent concerned about her own health. 20 8.7
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TABLE II
Concerns about having an HIV test
Concern Number Percentage
It might be positive. 5 33.3
It might affect my insurance. 9 60
It might not be totally confidential. 4 26.7
a consent form prior to testing, whereas 25.1%
(56/223) couldn't remember. Ofthe 70.4% who
recalled signing consent, 96.8% (152/157) felt
the consent obtained was appropriate.
Table III shows the time at which decision to
have the test was made. If the woman was
accompanied, she was asked if the individual
present influenced her decision to have the test
and 98.4% (184/187) stated that they had not.
DISCUSSION
There has been much debate concerning the best
way to offer antenatal HIV screening, be it
universal, selective, oronrequest. This studyhas
shown a very high uptake rate with a universal
policy. The uptake of 98.7% compares very
favourably with other studies such as the
Edinburgh study in 1999 which had an 88%
uptake 9 and a tertiary referral hospital in the
West Midlands with low prevalence similar to
our study had a 80% acceptance rate.'0
The most common reason foropting out was that
thewomenfeltthey were atlowrisk, andthis was
also the case in the West Midlands study.10 It is
possible that the acceptance level in our study
was particularly high because the prevalence of
HIV, and thus perceived risk, in the local
population is extremely low, and there is only a
very small ethnic minority community. In the
West Midlands study, ethnic minority women
werealmosttwiceaslikelytooptoutasCaucasian
women (28% Afro-Caribbean and 25% Asian
compared with 15% Caucasian).
A common misconception is that having the test
may affect insurance or life assurance. In the
event of a negative test, this is not the case. The
misconception has probably arisen because, in
the past, insurance proposal forms asked the
respondent ifthey had ever been tested for HIV,
and this was used as a measure of risk. Now,
formsissuedbycompaniesaffiliatedtotheBritish
Association ofInsurers ask ifthe respondent has
tested positive for HIV. This is a point which
requires explanation and reassurance.
Our study showed that a high acceptance rate
couldbeachievedbyasimplepatientinformation
leaflet and a suitably qualified midwife with a
short period of time dedicated to explaining the
test. It was also notable that the women were
happy with the amount of information they
received, and the majority had little anxiety or
concern about having the test.
Anareawhichcouldbeimprovedwasthelevelof
privacy affordedtoourpatients, withonly 74.3%
feeling there was enough privacy. This was
probably a result ofpatients being counselled in
a large room with 4 alcoves. This issue will be
resolved in the future when the maternity unit
moves to a new building, which will have
individual booking rooms.
CONCLUSION
We have shown that with forward planning and
adequatetraining ofmedical staffitispossible to
TABLE III
Timing ofdecision whether or not to have the HIV test
Time ofdecision-making Number Percentage
Prior to receiving hospital information. 40 19.1
After receiving hospital information but prior to
attending for booking visit. 86 41.2
When attending for the booking visit but prior to
discussion with the midwife. 38 18.2
At the booking visit and after speaking to the midwife. 45 21.5
C The Ulster Medical Society, 2004.
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have a high acceptance ofHIV testing as well as
having a high level ofpatient satisfaction.
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